compounding pharmacies and have not been reviewed by the FDA for safety, effectiveness, or quality
No human randomized controlled trial on BPC-157 capsules has been published or completed as of mid-2026
Yang S-N, Shi Y, Yang G, Li Y, Yu J, Berggren P-O (2014) Ionic mechanisms in pancreatic cell signaling
AIMED, 16, doi: 10.1016/j.aimed.2015.11.002 (2015)
GLP-1 is an incretin hormone that stimulates insulin secretion in a glucose-dependent manner, reducing hypoglycaemia risk The hormone slows gastric emptying and suppresses appetite through receptors in the pancreas, brain, and gastrointestinal tract GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) are MHRA-approved for type 2 diabetes and weight management Common side effects include nausea, vomiting, and diarrhoea due to delayed gastric emptying and altered gut motility Patients should seek urgent medical attention for severe abdominal pain with persistent vomiting, as this may indicate pancreatitis GLP-1 medications do not directly impair digestive enzyme production, and routine enzyme supplementation is not clinically indicated Table of Contents What Does GLP-1 Stand For